Corneal Cross-Linking

An ophthalmic treatment used to prevent weakening or bulging of the CORNEA in corneal ECTASIA, e.g., post-LASIK ectasia, KERATOCONUS and pellucid marginal corneal degeneration. It uses UV-A and RIBOFLAVIN to crosslink and strengthen COLLAGEN fibers within the cornea.

Also Known As:

CXL, Epi-off; CXL, Epi-on; CXL, Epithelium-off; CXL, Epithelium-on; CXL, Transepithelial; Collagen Cross-Linking, Corneal; Collagen Cross-Linkings, Corneal; Corneal Collagen Cross Linking; Corneal Collagen Cross-Linkings; Corneal Cross Linking; Corneal Cross-Linking, Epi-off; Corneal Cross-Linking, Epithelium-off; Corneal Cross-Linking, Epithelium-on; Corneal Cross-Linking, Transepithelial; Corneal Cross-Linkings; Cross-Linking, Corneal; Cross-Linking, Corneal Collagen; Cross-Linking, Epi-off Corneal; Cross-Linking, Epithelium-off Corneal; Cross-Linking, Epithelium-on Corneal; Cross-Linking, Transepithelial Corneal; Cross-Linkings, Corneal Collagen; Epi off CXL; Epi off Corneal Cross Linking; Epi on CXL; Epi-off CXLs; Epi-off Corneal Cross-Linkings; Epi-on CXLs; Epithelium off CXL; Epithelium off Corneal Cross Linking; Epithelium on CXL; Epithelium on Corneal Cross Linking; Epithelium-off CXLs; Epithelium-off Corneal Cross-Linkings; Epithelium-on CXLs; Epithelium-on Corneal Cross-Linkings; Transepithelial CXLs; Transepithelial Corneal Cross Linking; Transepithelial Corneal Cross-Linkings; Corneal Collagen Cross-Linking; Epi-off CXL; Epi-off Corneal Cross-Linking; Epi-on CXL; Epithelium-off CXL; Epithelium-off Corneal Cross-Linking; Epithelium-on CXL; Epithelium-on Corneal Cross-Linking; Transepithelial CXL; Transepithelial Corneal Cross-Linking

Therapeutics: 1158551
- Drug Therapy: 293145
  - Photochemotherapy: 17323
    - Corneal Cross-Linking: 1031
- Phototherapy: 7262
  - Photochemotherapy: 17323
    - Corneal Cross-Linking: 1031
- Combined Modality Therapy: 4307
  - Photochemotherapy: 17323
    - Corneal Cross-Linking: 1031

Jose M Benitez Del Castillo Selected Research

Jose M Benitez Del Castillo Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure